The FDA has approved the injectable version of Merc's cancer therapy, Kruda. That drug accounts for nearly half of Merc's revenue. And joining us right now on set is Robert Davis.He is the chairman and CEO of Merc. Also our very own Angelica Peebles. And welcome.It's good to see both of you. Uh Robert, let's talk about this first of all, the injectable version. Why is this better. Why will patients want this.>> Yeah. Well, well, first, you know, we're we're very excited about this because I do think this is ...